Drug Products, Including Biological Products, that Contain Nanomaterials - Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 21, 2022
April 21, 2022
0b0a870a-8d00-41ca-9657-6d9d2c754478
Related Documents
Bispecific Antibody Development Programs Guidance for Industry
Guidance DocumentMay 24, 2021Center for Drug Evaluation and Research
E11(R1) Addendum: Clinical Investigation of Medicinal Products in the Pediatric Population
Guidance DocumentApril 11, 2018Center for Drug Evaluation and Research
Elemental Impurities in Drug Products Guidance for Industry
Guidance DocumentAugust 8, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.